STOCK TITAN

Celia Huber Joins AMN Healthcare Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
management

AMN Healthcare (NYSE: AMN), a leader in healthcare total talent solutions, has announced the appointment of Celia Huber to its Board of Directors, effective May 2, 2025. Huber, currently a Senior Partner at McKinsey & Company, brings over 30 years of experience in healthcare strategy and leadership.

As the leader of McKinsey's Board Services Practice in North America, Huber specializes in advising Fortune 500 boards on governance, succession planning, and organizational transformation. Her extensive background includes counseling healthcare systems and payors on strategy, merger integration, and risk management.

Huber currently serves on the AltaMed Foundation board and the Executive Committee of the California Business Roundtable, demonstrating her commitment to healthcare leadership and organizational governance.

AMN Healthcare (NYSE: AMN), leader nelle soluzioni complete per il talento nel settore sanitario, ha annunciato la nomina di Celia Huber nel suo Consiglio di Amministrazione, a partire dal 2 maggio 2025. Huber, attualmente Senior Partner presso McKinsey & Company, vanta oltre 30 anni di esperienza nella strategia e nella leadership sanitaria.

Come responsabile della Board Services Practice di McKinsey in Nord America, Huber si specializza nel consulenza ai consigli di amministrazione di aziende Fortune 500 su governance, pianificazione della successione e trasformazione organizzativa. Il suo ampio background include la consulenza a sistemi sanitari e assicuratori su strategie, integrazione post-fusione e gestione del rischio.

Attualmente Huber fa parte del consiglio della AltaMed Foundation e del Comitato Esecutivo del California Business Roundtable, dimostrando il suo impegno nella leadership sanitaria e nella governance organizzativa.

AMN Healthcare (NYSE: AMN), líder en soluciones integrales de talento para el sector salud, ha anunciado el nombramiento de Celia Huber en su Junta Directiva, efectivo a partir del 2 de mayo de 2025. Huber, actualmente Socia Senior en McKinsey & Company, aporta más de 30 años de experiencia en estrategia y liderazgo en salud.

Como líder de la práctica Board Services de McKinsey en Norteamérica, Huber se especializa en asesorar a juntas directivas de empresas Fortune 500 sobre gobernanza, planificación de sucesión y transformación organizacional. Su amplia experiencia incluye asesorar a sistemas de salud y aseguradoras en estrategia, integración post-fusión y gestión de riesgos.

Actualmente, Huber forma parte de la junta de la AltaMed Foundation y del Comité Ejecutivo del California Business Roundtable, evidenciando su compromiso con el liderazgo en salud y la gobernanza organizacional.

AMN Healthcare (NYSE: AMN)는 의료 인재 솔루션 분야의 선두주자로서, 2025년 5월 2일부로 Celia Huber를 이사회 이사로 임명했다고 발표했습니다. 현재 McKinsey & Company의 시니어 파트너인 Huber는 의료 전략 및 리더십 분야에서 30년 이상의 경험을 보유하고 있습니다.

북미 지역 McKinsey의 이사회 서비스 부문을 이끄는 Huber는 Fortune 500 기업 이사회에 거버넌스, 승계 계획, 조직 혁신에 대해 자문하는 전문가입니다. 그녀의 폭넓은 경력은 의료 시스템과 보험사에 전략, 인수 통합, 위험 관리에 관한 조언을 포함합니다.

현재 Huber는 AltaMed 재단 이사회와 캘리포니아 비즈니스 라운드테이블 집행위원회에서 활동하며 의료 리더십과 조직 거버넌트에 대한 헌신을 보여주고 있습니다.

AMN Healthcare (NYSE : AMN), un leader des solutions globales de gestion des talents dans le secteur de la santé, a annoncé la nomination de Celia Huber au sein de son Conseil d'administration, à compter du 2 mai 2025. Huber, actuellement associée principale chez McKinsey & Company, apporte plus de 30 ans d'expérience en stratégie et leadership dans le domaine de la santé.

En tant que responsable de la pratique Board Services de McKinsey en Amérique du Nord, Huber se spécialise dans le conseil aux conseils d'administration des entreprises du Fortune 500 en matière de gouvernance, planification de la succession et transformation organisationnelle. Son vaste parcours comprend l'accompagnement des systèmes de santé et des payeurs sur la stratégie, l'intégration post-fusion et la gestion des risques.

Huber siège actuellement au conseil de la AltaMed Foundation ainsi qu'au comité exécutif du California Business Roundtable, témoignant de son engagement en faveur du leadership en santé et de la gouvernance organisationnelle.

AMN Healthcare (NYSE: AMN), ein führender Anbieter von umfassenden Talentlösungen im Gesundheitswesen, hat die Ernennung von Celia Huber in seinen Vorstand bekannt gegeben, wirksam ab dem 2. Mai 2025. Huber, derzeit Senior Partner bei McKinsey & Company, bringt über 30 Jahre Erfahrung in Gesundheitsstrategie und Führung mit.

Als Leiterin der Board Services Practice von McKinsey in Nordamerika spezialisiert sich Huber darauf, Fortune-500-Vorstände in den Bereichen Governance, Nachfolgeplanung und organisatorische Transformation zu beraten. Ihr umfangreicher Hintergrund umfasst die Beratung von Gesundheitssystemen und Kostenträgern zu Strategie, Merger-Integration und Risikomanagement.

Derzeit ist Huber Mitglied des Vorstands der AltaMed Foundation und des Exekutivausschusses des California Business Roundtable, was ihr Engagement für Führung im Gesundheitswesen und Organisationsgovernance unterstreicht.

Positive
  • Addition of seasoned healthcare industry expert with 30+ years of experience to the board
  • Expertise in governance, succession planning, and organizational transformation from leading McKinsey's Board Services Practice
  • Strong background in healthcare strategy and merger integration could support future growth initiatives
Negative
  • None.

Huber brings more than 30 years of experience across multiple sectors

DALLAS, June 24, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, announced the election of Celia Huber to its Board of Directors during its annual meeting of shareholders on May 2, 2025.

Huber’s background includes more than 30 years of experience advising healthcare systems, public and private sector payors and companies on strategy, risk and performance.

“Celia brings invaluable insight and leadership grounded in a career focused on governance, innovative partnerships and implementing new operating models successfully,” said Cary Grace, President and CEO of AMN Healthcare. “Her expertise at the intersection of mission-oriented work and healthcare leadership strategy aligns closely with AMN’s goals and objectives to deliver more effective, impactful workforce solutions that elevate patient care and support those who provide it.”

A Senior Partner at McKinsey & Company, Huber currently leads the firm’s Board Services Practice in North America, counseling Fortune 500 boards on governance, succession planning and organizational transformation. Throughout her career, Huber has advised healthcare systems, public and private sector payors and life sciences clients on strategy, merger integration, stakeholder alignment and emerging risks in the evolving healthcare landscape.

“I’ve spent much of my career working alongside healthcare leaders to tackle big challenges, and I see that same spirit of purpose and innovation at AMN. I’m looking forward to supporting the company’s mission and the people who make it possible, both behind the scenes and on the front lines of patient care,” said Huber.

Since 2021, Ms. Huber has served on the board of the AltaMed Foundation, the nonprofit fundraising arm for AltaMed Health Services, and she is also a member of the Executive Committee of the California Business Roundtable. Previously, she was a director for Citizens United for Research in Epilepsy (CURE) and served as Vice Chair of Make-A-Wish Greater Pennsylvania and West Virginia. Huber holds an MBA from Stanford University and a bachelor’s in finance from the University of Texas.

For more information about AMN Healthcare’s leadership team, please visit www.amnhealthcare.com.

About AMN Healthcare  
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies. 

Media Contact
Corporate Communications
AMN Healthcare
AMN-PR@amnhealthcare.com
Investor Contact
Randle Reece
Senior Director, Investor Relations & Strategy
AMN Healthcare
(866) 861-3229
investorrelations@amnhealthcare.com

FAQ

Who is Celia Huber and when did she join AMN Healthcare's board?

Celia Huber is a Senior Partner at McKinsey & Company who joined AMN Healthcare's Board of Directors on May 2, 2025. She brings over 30 years of experience in healthcare strategy and leadership.

What is Celia Huber's current role at McKinsey & Company?

Huber currently leads McKinsey & Company's Board Services Practice in North America, where she counsels Fortune 500 boards on governance, succession planning, and organizational transformation.

What experience does Celia Huber bring to AMN Healthcare's board?

Huber brings over 30 years of experience advising healthcare systems, public and private sector payors on strategy, merger integration, stakeholder alignment, and risk management in healthcare.

What other board positions does Celia Huber currently hold?

Huber serves on the board of the AltaMed Foundation since 2021 and is a member of the Executive Committee of the California Business Roundtable.
Amn Healthcare

NYSE:AMN

AMN Rankings

AMN Latest News

AMN Stock Data

836.98M
37.92M
0.92%
107.91%
10%
Medical Care Facilities
Services-help Supply Services
Link
United States
DALLAS